Cryoglobulinemic Glomerulonephritis in MYD88-Negative Waldenström Macroglobulinemia (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #SA-PO0793; Pres time: Oct 24, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "Although MYD88-negative WM is generally a more aggressive lymphoma, our patient had an indolent hematologic disease and absence of significant systemic tumor burden, but he developed severe nephritic syndrome secondary to cryoglobulinemic GN, which required prompt therapy. Rituximab-based therapy resulted in marked improvement supporting the pathogenic role of the underlying clonal B-cell disorder."
Acute Kidney Injury • B Cell Lymphoma • Fibrosis • Genetic Disorders • Glomerulonephritis • Hematological Malignancies • Hypertension • Immunology • Ischemic stroke • Lupus Nephritis • Lymphoma • Lymphoplasmacytic Lymphoma • Nephrology • Non-Hodgkin's Lymphoma • Non-melanoma Skin Cancer • Renal Disease • Skin Cancer • Solid Tumor • Waldenstrom Macroglobulinemia • ARID1A • CD20 • CD5 • FCER2 • MME • MYD88
|
|
Rami Al Assaad; Akram Audi
|